Our coverage is unrivalled in its depth, geographic scope and local insights. We enable you to make informed and strategic decisions in an ever-changing and highly competitive market.
Our medical device intelligence covers 16 key therapy areas and is available through comprehensive device modules to offer clients complete flexibility of choice.
We produce thousands of quantitative and qualitative reports annually, instantly available, to help you make more informed decisions quickly.
Our Intelligence Centers offer constantly updated data, investigative news, analysis and tools that slot seamlessly into your workflow to help you decode the future.
For fully bespoke independent insight with dedicated expert service, our consulting offering combines global capabilities with strong understanding of your local markets.
Following Tuesday’s (15t...
Following the news that the European Commission have approved Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) for previously untreated intermediate- or poor-risk ad...
After Theresa May’s historic Brexit deal defeat (Tuesday 15th January 2019), Gavin Davidson, Pharma Analyst at GlobalData, offers his view on how Brexit could impact the UK healthcare industry’s co...
contact online email@example.com
EMEA: +44 207 832 4399
APAC: +91 40 6616 6809
© GlobalData Plc 2019 | Registered Office: John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK Registered in England No. 03925319